Roy Blunt actually said...

First, for the past six years, this Committee and Congress have prioritized and invested in NIH. Within this timeframe, funding for medical ...

Members of this committee, most notably Senator Blunt, asked what NIH could do to ramp up innovation.

I mean, we know the impact in just the last half dozen years of immunotherapy on cancer treatment.

In a time of crisis, during shutdowns and social distancing, for a disease never seen before, the NIH and their nationwide system of grantee...